Written Question · S4W-21688 · Session 4
Further to the answer to question S4W-21127 by Michael Matheson on 28 May 2014, what progress each NHS board is making on achieving the nat…
The question
To ask the Scottish Government, further to the answer to question S4W-21127 by Michael Matheson on 28 May 2014, what progress each NHS board is making on achieving the national target for treatment initiations for 2013-14, and whether it expects the overall target to be met.
The answer
The Sexual Health and Blood Borne Virus Framework does not contain any board-specific targets for treatment initiations. Progress against the national target for number of persons commencing therapy is detailed in the following table.
The targets set out in the Sexual Health and Blood Borne Virus Framework were informed by a long-term goal to significantly change the shape of the epidemic in Scotland, and were based on the hepatitis C therapies in use at the time the framework was written. Since the framework was published there have been changes to standard therapies for hepatitis C in Scotland, including the introduction of protease inhibitors in 2012-13, which have improved treatment outcomes for many patients, and which mean more people commencing treatment are clearing the virus.
Decisions about initiating treatment must be made by clinicians and patients together. Some patients may choose to delay commencing treatment for a range of reasons, in discussion with clinicians.
Year
2009-10
2010-11
2011-12
2012-13
2013-14*
Number of persons commencing therapy
904
1049
1002
1052
1000
Scotland target
750
1000
1100
1150
1200
*Data for 2013-14 is provisional
The targets set out in the Sexual Health and Blood Borne Virus Framework were informed by a long-term goal to significantly change the shape of the epidemic in Scotland, and were based on the hepatitis C therapies in use at the time the framework was written. Since the framework was published there have been changes to standard therapies for hepatitis C in Scotland, including the introduction of protease inhibitors in 2012-13, which have improved treatment outcomes for many patients, and which mean more people commencing treatment are clearing the virus.
Decisions about initiating treatment must be made by clinicians and patients together. Some patients may choose to delay commencing treatment for a range of reasons, in discussion with clinicians.
Year
2009-10
2010-11
2011-12
2012-13
2013-14*
Number of persons commencing therapy
904
1049
1002
1052
1000
Scotland target
750
1000
1100
1150
1200
*Data for 2013-14 is provisional
In the Official Report
No contribution in the Official Report cites S4W-21688 by reference.